VYNE

Vyne Therapeutics Inc

0.8078

+0.0468+6.15%

Pre Market: 0.6672 -0.1406 -17.41%05:56 07/21 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.7700/0.7610

TODAY RANGE0.7550-0.8174

VOL168.78K

MARKET CAP26.97M

52 WEEK RANGE0.2805-1.595

AVG VOL (3M)600.58K

% TURNOVER6.72%

TURNOVER0

P/E (TTM)-1.6111

% RANGE8.20%

EPS(TTM)-0.5014

P/E(FORWARD)-1.3692

P/B1.094

BVPS0.7387

DIVIDEND--

P/S47.24

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP21.96M

SHARES OUTSTANDING33.39M

NEXT EARNINGS08/12-08/17

FREE FLOAT27.19M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

PUBT·1d ago
Vyne Therapeutics holds shareholder special meeting on merger proposals
TipRanks·6d ago
VYNE Therapeutics advances reverse merger with Yarrow Bioscience
Seeking Alpha·07/13 04:45
VYNE Therapeutics declares $0.38/share merger-contingent special dividend
TipRanks·07/10 12:28
VYNE declares special dividend ahead of Yarrow merger
TipRanks·07/10 12:11
VYNE Therapeutics declares special cash dividend with Yarrow Bioscience merger
PUBT·07/10 12:01
Vyne Therapeutics announces special shareholder meeting on proposed Yarrow merger
Dow Jones·07/10 12:01
*Vyne Therapeutics Will Pay Special Cash Div of $16.5M, or 38c Per Shr >VYNE
Reuters·07/10 12:00
VYNE THERAPEUTICS - SPECIAL CASH DIVIDEND ESTIMATED AT $16.5 MLN, OR $0.38 PER SHARE, RECORD DATE JULY 22, 2026
Dow Jones·07/10 12:00
Press Release: VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience
Dow Jones·07/10 12:00
Press Release: VYNE Therapeutics Declares Special -2-
Dow Jones·07/10 12:00
*VYNE Therapeutics Declares Special Cash Dividend In Connection With The Proposed Merger With Yarrow Bioscience >VYNE
Seeking Alpha·06/12 10:38
These healthcare stocks are combining strong gains with reasonable prices
PUBT·06/02 13:00
Vyne Therapeutics publishes investor presentation on Yarrow Bioscience, YB-101 anti-TSHR program for Graves' disease, thyroid eye disease
TipRanks·05/21 23:51
VYNE Highlights Yarrow Merger Strategy and Endocrine Pipeline
PUBT·05/21 21:05
Vyne Therapeutics publishes Yarrow Bioscience investor presentation factsheet

Same Industry

Name/Symbol

Change%

Price

VYNE

REGN

GridAI Tech

GRDX

+0.26%

3.820

BNTX

United Therapeutics Corp.

UTHR

+1.25%

535.67

Vertex Pharmaceuticals Inc

VRTX

-0.08%

485.65

Siga Technologie

SIGA

-3.37%

3.440

MRNA

Charles Riv Labs Intl Inc

CRL

-2.07%

219.70

Medpace Holdings

MEDP

-1.82%

527.93

TLPH

ICLR

CBPO

Iqvia Hldgs Inc

IQV

-1.14%

203.90

MOLN

Arcturus Therape

ARCT

-2.10%

6.05

Gilead Sciences Inc

GILD

-1.48%

134.28

PRAH

Incyte Corp

INCY

+0.51%

117.25

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.